PROCEPT BioRobotics Corporation / Fundamentals
Income statement
- Net revenue
€235.91M - Cost of goods sold
€84.48M - Gross profit
€151.43M - SG&A expenses
€173.75M - R&D expenses
€56.41M - EBITDA
-€69.49M - D&A
€2.39M - EBIT
-€78.73M - Interest expenses
€288.29K - EBT
-€72.20M - Tax expenses
€0.00 - Net income
-€72.20M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€1.60M - Changes in working capital
-€36.83M - Operating cash flow
-€71.40M - Capex
€5.20M - Other investing cash flow
€0.00 - Net investing cash flow
-€5.20M - Total cash dividends paid
€0.00 - Issuance of common stock
€133.28M - Debt repayment
€0.00 - Other financing cash flow
€7.74M - Net financing cash flow
€152.65M - Foreign exchange effects
-€19.73K - Net change in cash
€78.65M - Cash at end of period
€262.34M - Free cash flow
-€66.20M
Balance sheet
- Cash and cash equivalents
€259.73M - Cash and short-term investments
€259.73M - Total receivables
€69.34M - Inventory
€57.51M - Other current assets
€6.44M - Total current assets
€393.02M - Property, plant & equipment
€40.21M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€2.61M - Other non-current assets
€3.68M - Total non-current assets
€47.18M - Total assets
€440.20M - Accounts payable
€10.11M - Short-term debt
€1.77M - Other current liabilities
€22.30M - Total current liabilities
€42.67M - Long-term debt
€66.33M - Deferred tax liabilities
€0.00 - Other non-current liabilities
-€66.52M - Total non-current liabilities
€0.00 - Total liabilities
€0.00 - Common stock
€0.00 - Retained earnings
-€506.48M - Other equity
-€123.55K - Total equity
€331.01M - Total liabilities and shareholders' equity
€440.20M
Company information
- Market capitalization
€2.69B - Employees
756 - Enterprise Value
€3.20B
Company ratios
- Gross margin
-
64.2% Even with peer group: 62.8% - EBITDA margin
-
-29.5% Worse than peer group: -23.7% - EBIT margin
-
-33.4% Even with peer group: -30.9% - EBT margin
-
-30.6% Much worse than peer group: -3.0% - Net margin
-
-30.6% Even with peer group: -32.0% - ROE
-
-21.8% Much worse than peer group: 38.3% - ROA
-
-16.4% Worse than peer group: -7.3% - Asset turnover
-
53.6% Worse than peer group: 67.1% - FCF margin
-
-32.5% Worse than peer group: -23.0% - FCF yield
-2.9% - Efficiency ratio
129.5% - Net sales per employee
-
€312.05K - Net income per employee
-
-€95.50K